Previous Close | 0.0750 |
Open | 0.0750 |
Bid | 0.0750 x N/A |
Ask | 0.0800 x N/A |
Day's Range | 0.0750 - 0.0850 |
52 Week Range | 0.0500 - 0.8000 |
Volume | |
Avg. Volume | 33,058 |
Market Cap | 2.376M |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Mikra completes design of new product that delivers superior clarity of cognition and improved memory in collaboration with Jose Bautista and advances shipment date FOCUS combines a precision blend of citicoline, tyrosine and pure lion's mane mushroom to deliver superior clarity of cognition and improved memory. TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advance
Lifeist Sells Non-Core Subsidiary to Sharpen its Strategic Focus on Nutraceuticals and B2B Recreational CannabisTORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. (“Aussie Vapes”), its wholly owned Australian su
TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that, further to its news release dated April 30, 2024, the TSX Venture Exchange (the "Exchange") has approved the consolidation of the Company’s issued and outstanding common shares on the basis of one (1